quinoxalines has been researched along with Polyploid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, Y; Ishii, M; Kanagawa, O; Kim, H; Miyawaki, A; Mizuno, H; Sakaue-Sawano, A; Takegahara, N; Tomura, M | 1 |
Joiakim, A; Kleinman, M; Mathieu, PA; Reiners, JJ | 1 |
2 other study(ies) available for quinoxalines and Polyploid
Article | Year |
---|---|
Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts.
Topics: Animals; Benzimidazoles; Biomarkers; Bone Marrow Cells; Cell Fusion; Cell Nucleus; Cells, Cultured; Crosses, Genetic; Cytokinesis; Luminescent Proteins; Male; Mice, Transgenic; Myeloid Progenitor Cells; Osteoclasts; Osteogenesis; Osteolysis; Phosphorylation; Polyploidy; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinoxalines; RANK Ligand; Recombinant Fusion Proteins | 2016 |
The chemotherapeutic agents XK469 (2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid) and SH80 (2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid) inhibit cytokinesis and promote polyploidy and induce senescence.
Topics: Animals; Autophagy; Cell Division; Cell Line; Cells, Cultured; Cellular Senescence; Cytokinesis; Flow Cytometry; Mice; Peptide Hydrolases; Polyploidy; Propionates; Quinoxalines | 2009 |